278 related articles for article (PubMed ID: 20513304)
1. The effectiveness of harm reduction in preventing HIV among injecting drug users.
Wodak A; Maher L
N S W Public Health Bull; 2010; 21(3-4):69-73. PubMed ID: 20513304
[TBL] [Abstract][Full Text] [Related]
2. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.
Wodak A; Cooney A
Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167
[TBL] [Abstract][Full Text] [Related]
3. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
Takács IG; Demetrovics Z
Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
[TBL] [Abstract][Full Text] [Related]
4. Estimating the cost-effectiveness of needle-syringe programs in Australia.
Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
[TBL] [Abstract][Full Text] [Related]
5. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F; Fatima M
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
[TBL] [Abstract][Full Text] [Related]
6. HIV and injecting drug use in Indonesia: epidemiology and national response.
Afriandi I; Aditama TY; Mustikawati D; Oktavia M; Alisjahbana B; Riono P
Acta Med Indones; 2009 Jul; 41 Suppl 1():75-8. PubMed ID: 19920303
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
[TBL] [Abstract][Full Text] [Related]
10. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
11. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
Maher L; Iversen J; Kaldor J
Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
[No Abstract] [Full Text] [Related]
12. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
13. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J; Desenclos JC
Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
[TBL] [Abstract][Full Text] [Related]
14. Malaysia and harm reduction: the challenges and responses.
Reid G; Kamarulzaman A; Sran SK
Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
[TBL] [Abstract][Full Text] [Related]
15. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
[TBL] [Abstract][Full Text] [Related]
16. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
Amundsen EJ
Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
[No Abstract] [Full Text] [Related]
17. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
[TBL] [Abstract][Full Text] [Related]
19. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
Panda S; Sharma M
Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
[TBL] [Abstract][Full Text] [Related]
20. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
Ritter A; Cameron J
Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
